| Dr Sarah E Bernard, MD | |
|
1601 E Broadway, Suite 100, Columbia, MO 65201 | |
| (573) 443-8796 | |
| (573) 875-3949 |
| Full Name | Dr Sarah E Bernard |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 1601 E Broadway, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801091814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2010003842 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boone Hospital Center | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Health Associates, Inc. | 9739078916 | 10 |
News Archive
The Global Health Innovative Technology Fund (GHIT Fund) announced today that it's investing US$1,383,785 in a pair of innovative malaria eradication tools—a vaccine that could block transmission of two species of the deadly disease and a rapid field test that can reveal a malaria infection in minutes.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
Treating girls with Turner syndrome with low-dose oestrogen from childhood results in earlier thelarche and a slower tempo of puberty, research shows.
ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.
› Verified 3 days ago
| Entity Name | Women's Health Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417926676 PECOS PAC ID: 9739078916 Enrollment ID: O20040315000565 |
News Archive
The Global Health Innovative Technology Fund (GHIT Fund) announced today that it's investing US$1,383,785 in a pair of innovative malaria eradication tools—a vaccine that could block transmission of two species of the deadly disease and a rapid field test that can reveal a malaria infection in minutes.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
Treating girls with Turner syndrome with low-dose oestrogen from childhood results in earlier thelarche and a slower tempo of puberty, research shows.
ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah E Bernard, MD 1601 E. Broadway, Suite 100, Columbia, MO 65201 Ph: (573) 443-8796 | Dr Sarah E Bernard, MD 1601 E Broadway, Suite 100, Columbia, MO 65201 Ph: (573) 443-8796 |
News Archive
The Global Health Innovative Technology Fund (GHIT Fund) announced today that it's investing US$1,383,785 in a pair of innovative malaria eradication tools—a vaccine that could block transmission of two species of the deadly disease and a rapid field test that can reveal a malaria infection in minutes.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
Treating girls with Turner syndrome with low-dose oestrogen from childhood results in earlier thelarche and a slower tempo of puberty, research shows.
ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.
› Verified 3 days ago
Rose Elizabeth Todd, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Lindsey Taylor Ellis, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St # Dc570.00, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Madalyn Michelle Barnett, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Abby Marie Lombardi, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St # Dc570.00, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Kaley Holloway Hankins, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Michael S Cardwell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 500 N. Keene St, Suite 406, Columbia, MO 65201 Phone: 573-499-6041 Fax: 573-499-6091 | |
Breton Foster Barrier, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2325 Smiley Ln, Columbia, MO 65202 Phone: 573-817-3535 Fax: 573-817-3536 |